Evaluation of drugs in experimental gut distension models

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 13, Issue 2, 1999, Pages 54-56

  Pappas, T N ^a,b   Mangel, A W ^c   Lawson, C ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Geriat Res Educ/Clinical Center   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; SEROTONIN 3 ANTAGONIST; CARBOLINE DERIVATIVE; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DOG; INTESTINE DISTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; ABDOMINAL PAIN; ANIMAL; DISEASE MODEL; IRRITABLE COLON; REVIEW;

ABDOMINAL PAIN; ANIMALS; CARBOLINES; COLONIC DISEASES, FUNCTIONAL; DISEASE MODELS, ANIMAL; DOGS; SEROTONIN ANTAGONISTS;

EID: 0032919604     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Lasser RB, Bond JH, Levitt MD. The role of intestinal gas in functional abdominal pain. N Engl J Med 1975; 293: 524-6.
2. Schuster MM. Irritable bowel syndrome. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis and Management. Philadelphia: Saunders. 1989: 1402-18.
3. Serra J, Azpiroz F, Malagelada JR. Intestinal gas dynamics and tolerance in humans. Gastroenterology 1998; 115: 542-50.
4. Ness TJ, Gebhart GF. Visceral pain: a review of experimental studies. Pain 1990; 41: 167-234.
5. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterisation of pseudoaffective reflexes in the rat Brain Res 1988; 450: 153-69.
6. Ness TJ, Randich A, Gebbart GF. Further behavioral evidence that colorectal distension is a 'noxious' visceral stimulus in rats. Neurosci Lett 1991; 131: 113-6.
7. Bjorkman R, Hedner J, Hedner T, Henning M. Central naloxone reversible antinociception by diclofenac in the rat. Naunyn Schmeidebergs Arch Pharmacol 1990; 342: 171-6.
8. Clark SJ, Follenfant RL, Smith TW. Evaluation of opioid-induced antinociceptive effects in anaesthetized and conscious animals. Br J Pharmacol 1988; 95: 275-83.
9. Maves TJ, Pechman PS, Meller ST, Gebhart GF. Ketorolac potentiates morphine antinociception during visceral nociception in the rat. Anesthesiology 1994; 80: 1094-101.
10. Burton MB, Gebhart GF. Effects of kappa-opioid receptor antagonists on responses to colorectal distension in rats with and without acute colonic inflammation J Pharmacol Exp Ther 1998; 285: 707-15.
11. Langlois A, Diop L, Riviere PJM, Pasaud X, Junien JL. Efect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anesthetized rat. Eur J Pharmacol 1994; 271: 245-51.
12. Ness TJ, Follett KA. The development of tolerance to intrathecal morphine in rat models of visceral and cutaneous pain. Neurosci Lett 1998; 248: 33-6.
13. Maves TJ, Gebhart GF. Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in the rat. Anesthesiology 1992; 76: 91-9.
14. Borgbjerg FM, Frigast C, Madsen JB, Mikkelsen LF. The effect of intrathecal opioid-receptor agonists on visceral noxious stimulation in rabbits. Gastroenterology 1996; 110: 139-46.
15. Bozkurt P, Tunali Y, Kaya G. Evaluation of antinociceptive effects of epidural and intramuscular midazolam in rabbits. Agri Derg 1996; 8: 26-32.
16. 3 receptor antagonist. Dig Dis Sci 1999; 44: 20-4.
17. 3 receptor antagonists on the depressor response to colorectal distension in the anaesthetised rat. Br J Pharmacol 1994; 112: 101P.
18. 3 receptor antagonism modulates a noxious visceral pseudoaffective reflex. Neuropharmacol 1995; 34: 263-7.
19. Scott CM, Grundy D, Boissonade D, Bountra C. Alosetron inhibits the colorectal distension evoked depressor response and spinal c-fos expression in the anaesthetised rat. Gastroenterol 1997; 112: A822 (Abstract).
20. 3 receptor antagonists in modulation of visceral hypersensitivity. Br J Pharmacol 1995; 114: 558-62.